The approvals of Onpattro, Givlaari, Oxlumo, and Leqvio combined with several partnerships have bolstered Alnylam's cash balance, and the company concluded fiscal 2024 with $2.69 billion in cash, cash ...

Pro Apparel KC owner and retired firefighter John Sirna is selling hats to benefit the family of Graham Hoffman, with 100% of ...

Registration Link for Presentation and live Q&A to take place, Wednesday, May 7, 2025 at 2:00 pm EST Marlborough, Massachusetts--(Newsfile Corp. - May 1, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: ...

This week on Where’s It Wednesday, we head down to sunny Southern California to visit the hometown of NBC5 news anchor ! A ...

Itoophiyaan oomisha tamirii oomishuuf biyya oomisha tamiriin beekamtu Yunaayitid Arab Emireetis (UAE) waliin waliigaltee ...

Vir Biotechnology Inc. advanced stock charts by Barron's. View VIR historical stock data and compare to other stocks, and exchanges.

Scientists develop RNA-based technology to combat plant viruses, enhancing crop immunity and reducing losses worldwide.

Rona Therapeutics Co. Ltd. has obtained IND clearance from China′s National Medical Products Administration (NMPA) for RN-1871, a small interfering RNA (siRNA) drug targeting angiotensinogen (AGT) for ...

China NMPA approves Rona Therapeutics’ IND application for RN1871, a novel AGT-targeting siRNA drug for hypertension: Shanghai, China Tuesday, April 22, 2025, 18:00 Hrs [IST] Ro ...

SHANGHAI, April 21, 2025 /PRNewswire/ -- Rona Therapeutics, a biotechnology company pioneering innovative RNA-targeted therapies, announced that the Investigational New Drug (IND) application for ...

Researchers from Eli Lilly & Co. reported preclinical data on LY-3954068, a MAPT small-interference RNA (siRNA) strategy in AD models. The therapy is designed to reduce tau protein synthesis by ...